UNSPSC 51111651: Pirazofurin or pyrazofurin

This classification denotes a pyrimidine antagonist and orotidylate decarboxylase inhibitor with the molecular formula C9H13N3O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4B15044GQZ, chemically known as 1h-pyrazole-5-carboxamide, 4-hydroxy-3-beta-d-ribofuranosyl- but generally known as pirazofurin, which bears US NIH Compound Identifier 5360877. European Medicines Agency schedules Pirazofurin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09897MIG.

UNSPSC 51111651 Pirazofurin or pyrazofurin is a Commodity code with minimal recent state and local procurement activity aligned to its nominal scope. The single recent opportunity on record — Texas Health and Human Services Commission's Request for Information No. HHS0017013, posted April 3, 2026 — addresses direct-to-manufacturer prescription fulfillment and pharmacy benefit program design, not the procurement or supply of pirazofurin or related pharmaceutical compounds as a discrete product line. The RFI seeks vendor capabilities for establishing direct contracting relationships between state pharmacy benefit programs and manufacturers to improve prescription fulfillment efficiency and cost management, with emphasis on vendors' experience in direct contracting for self-insured employers and health plans, flexibility in negotiated net pricing models, and capacity to implement value-based or outcomes-based agreements. This represents market intelligence gathering rather than active procurement of the specific pharmaceutical substance the code nominally describes.

The code shows no evidence of regular solicitation activity across state and local jurisdictions. The Texas HHS Commission RFI is exploratory in nature and was designed to inform future procurement strategy before formal competitive solicitations are issued; no award value, budget range, set-asides, or binding timelines are specified. State and local buyers do not appear to be actively procuring pirazofurin as a line item under this code. Business development professionals should consider this code inactive for current pursuit unless upstream intelligence indicates that the Texas HHS pharmacy program will move to formal RFP with pharmaceutical commodity specifications aligned to the UNSPSC code itself.